MicroRNA Market Report 2026

MicroRNA Market Overview

• MicroRNA market size has reached to $1.57 billion in 2025 • Expected to grow to $3.32 billion in 2030 at a compound annual growth rate (CAGR) of 15.6% • Growth Driver: Rising Cancer Cases Fuels Growth In MicroRNA Market • Market Trend: Innovative Mirna Probe Customization Services Elevate Research And Clinical Applications • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under MicroRNA Market?

MicroRNAs are small, non-coding RNA molecules, typically about 20-22 nucleotides in length, used to regulate gene expression. They function by binding to complementary sequences on messenger RNA (mRNA) molecules, usually resulting in gene silencing through translational repression or target degradation. The main products of microRNA are instruments and consumables. MicroRNA instruments refer to the tools and equipment used for analyzing microRNA, such as microarray scanners and PCR machine. The various assay types involved are immunoassay, next-generation sequencing, miRNA arrays, and polymerase chain reaction (PCR) based arrays which are used for cancer, infectious diseases, immunological disorders, cardiovascular disease, neurological disease, and other applications by academic and research institutes, biopharmaceutical companies, diagnostic centers, clinical research organizations.

What Is The MicroRNA Market Growth Forecast?

The microrna market size is expected to see rapid growth in the next few years. It will grow to $3.32 billion in 2030 at a compound annual growth rate (CAGR) of 15.6%. The growth in the forecast period can be attributed to increasing clinical applications of microrna diagnostics, rise in personalized medicine usage, growth in therapeutic microrna development, expansion of infectious disease research, rising investments in molecular assay technologies. Major trends in the forecast period include expansion of precision genomics, AI-driven microrna expression analysis, growth in cloud-based sequencing data storage, automation in molecular diagnostics, iot-enabled laboratory workflow integration.

Global MicroRNA Market Segmentation

1) By Product: Instruments, Consumables 2) By Assay Type: Immunoassay, Next Generation Sequencing, MiRNA Arrays, Polymerase Chain Reaction (PCR) Based Arrays 3) By Application: Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease, Other Applications 4) By End User: Academic And Research Institutes, Biopharmaceutical Companies, Diagnostic Centers, Clinical Research Organizations Subsegments: 1) By Instruments: Quantitative PCR Systems, Microarray Platforms, Next-Generation Sequencing (NGS) Systems, Real-Time PCR Instruments, Microrna Analyzers 2) By Consumables: MicroRNA Kits ( Extraction Kits, Detection Kits), PCR Reagents, Primers And Probes, Microarrays And Chips, RNA Sequencing Kits

What Is The Driver Of The MicroRNA Market?

The increasing number of cancer cases is expected to propel the growth of the microRNA market going forward. Cancer refers to a complex disease characterized by uncontrolled cell growth and proliferation, often leading to the formation of malignant tumors that can invade surrounding tissues and spread to distant organs, posing significant health risks. The increasing number of cancer cases is due to various factors, including aging populations, lifestyle choices such as smoking and poor diet, environmental pollutants, and improved detection methods leading to earlier diagnosis. MicroRNA is combined with traditional cancer therapies to enhance drug sensitivity and improve outcomes. Beyond treatment, miRNAs serve as diagnostic and prognostic biomarkers, helping to identify cancer types, predict disease progression, and monitor treatment responses. For instance, in May 2024, according to the National Cancer Institute, a US-based government agency, around 20 million new cases and 9.7 million cancer-related deaths were recorded annually in 2022, and predictions indicate that by 2040, there would be 15.3 million deaths and 29.9 million new cases per year. Therefore, the increasing number of cancer cases is driving the growth of the microRNA industry.

Key Players In The Global MicroRNA Market

Major companies operating in the microrna market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc, Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Miltenyi Biotec, LGC Limited, Promega Corporation, Abcam plc, Integrated DNA Technologies Inc., NanoString Technologies Inc., Horizon Discovery Ltd., OriGene Technologies Inc., Omega Bio-Tek, New England Biolabs, Quantabio, SeqMatic LLC, GeneCopoeia Inc., HTG Molecular Diagnostics Inc.

Global MicroRNA Market Trends and Insights

Major companies operating in the microRNA market are focusing on developing advanced solutions such as miRNA probe customization services to meet the specific needs of researchers and clinicians, enhance the accuracy of miRNA detection, and facilitate a wide range of applications. MiRNA probe customization services refer to specialized services offered by biotechnology and molecular biology companies to design and produce customized probes specific to particular microRNAs (miRNAs) for various research and clinical applications. For instance, in September 2023, Abnova Corporation, a Taiwan-based biotech company, launched enhanced services for customizing miRNA probes, along with a new range of cataloged miRNA probes, to meet the diverse needs of academic, industrial, and research communities engaged in miRNA research. These probes play a crucial role in identifying and precisely locating miRNAs, which are small, non-coding RNA molecules vital for various biological processes. Abnova's customization services ensure high specificity and minimal cross-reactivity, making them well-suited for analyzing samples with limited miRNA content.

What Are Latest Mergers And Acquisitions In The MicroRNA Market?

In May 2024, Bruker Corporation, a US-based scientific instruments company acquired NanoString Technologies Inc. for approximately $392.6 million. With this acquisition, Bruker aims to enhance its capabilities in gene expression profiling and spatial transcriptomics, further solidifying its position in the life sciences research market. NanoString Technologies Inc. is a US-based biotechnology company, specializes in providing solutions for gene expression analysis.

Regional Outlook

North America was the largest region in the microRNA market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the MicroRNA Market?

The microRNA market consists of revenues earned by entities by providing services such as microRNA sequencing and data analysis services, microRNA therapeutic development services, and microRNA profiling services. The market value includes the value of related goods sold by the service provider or included within the service offering. The microRNA market also includes sales of microRNA extraction kits, microRNA detection kits, microRNA quantification kits, and microRNA expression arrays. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the MicroRNA Market Report 2026?

The microrna market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the microrna industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.